Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2014-10-28 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RaySearch Får FDA-godkännande för RayStation 4.5 med ultrasnabb och robust optimering
Regulatory Filings Classification · 97% confidence The document is a press release dated October 28, 2014, announcing that RaySearch Laboratories AB has received FDA clearance for version 4.5 of its RayStation dosimetric planning system. The text details new features, performance improvements (speed, optimization), and clinical validation studies related to the software update. This is a general announcement about a product/technology update and regulatory milestone, not a formal financial report (like 10-K, IR, or ER), nor is it a management change (MANG) or a shareholder vote result (DVA). Since it is a specific announcement about a regulatory achievement (FDA approval) and product launch details, it fits best under the general 'Regulatory Filings' (RNS) category as a significant, non-financial regulatory event announcement, or potentially a 'Report Publication Announcement' (RPA) if it were announcing the release of a detailed technical report, but here it is announcing the clearance itself. Given the options, RNS serves as the best fit for a significant, non-standard regulatory/product news release that isn't a core financial filing or management change.
2014-10-28 Swedish
RaySearch and Mevion announce strategic partnership
Regulatory Filings Classification · 98% confidence The document announces a strategic partnership between two companies, RaySearch and Mevion Medical Systems, regarding the development of treatment planning solutions for proton therapy technology (HYPERSCAN). This is a business development announcement concerning collaboration, technology integration, and market strategy, rather than a standard regulatory financial filing (like 10-K, ER, or IR). It does not fit the definitions for AGM-R, DVA, DIV, or specific financial reports. It is a general corporate announcement about a business agreement. Since there is no specific category for 'Partnership Announcement' or 'Business Development,' the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that do not fit the highly specific financial or governance codes provided.
2014-09-15 English
RaySearch och Mevion tillkännager strategiskt samarbete
Regulatory Filings Classification · 95% confidence The document is a press release dated September 15, 2014, announcing a strategic collaboration between RaySearch and Mevion Medical Systems regarding advanced dose planning solutions for proton therapy. It details a partnership, quotes executives, and describes the technologies involved (RayStation®, HYPERSCAN, Mevion S250). This type of announcement, detailing a business agreement or partnership, does not fit neatly into the specific financial reporting categories (10-K, ER, IR, etc.). It is a general corporate announcement. Since it is not a director's dealing, capital change, dividend notice, or management change, the most appropriate general category for a significant corporate announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous corporate news releases.
2014-09-15 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB for the period January 1 to June 30, 2014. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and detailed management commentary on business performance, market trends, and operational highlights. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2014
2014-08-27 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report for RaySearch Laboratories AB for the period January 1 to June 30, 2014. It contains detailed financial statements, management commentary, analysis of sales and earnings, and significant events. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis, nor is it a full annual report (10-K). Therefore, it fits the definition of an Interim/Quarterly Report (IR). H1 2014
2014-08-27 English
First PBS / IMPT proton treatments with RayStation
Regulatory Filings Classification · 90% confidence The document is a press release dated June 10, 2014, announcing a significant operational milestone: the first patient treatments using the RayStation planning system with Pencil Beam Scanning (PBS) at the Provision Center for Proton Therapy. This type of announcement, detailing a specific business achievement, partnership success, or operational update, does not fit neatly into the defined financial reporting categories (10-K, IR, ER, etc.). It is a general corporate announcement regarding technology implementation and partnership success. Since it is not a formal regulatory filing like a 10-K, nor a specific financial report, nor a management change, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements that don't fit elsewhere.
2014-06-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.